Article ID Journal Published Year Pages File Type
10509447 Drug and Alcohol Dependence 2013 6 Pages PDF
Abstract
LY379268 selectively reduced the motivation to self-administer METH. In contrast to data with other compounds, the sensitivity to the effects of LY379268 did not change following extended access to METH self-administration. Group II mGluR agonists, therefore, may represent a relatively new class of compounds for the development of pharmacotherapies for METH addiction.
Related Topics
Life Sciences Neuroscience Behavioral Neuroscience
Authors
, , ,